section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in Ringer’s injection, lactated.

d Preservative free.

e Injected via Y-site into an administration set running azithromycin.

f Final concentration after mixing.

g Tested in both dextrose 5% and sodium chloride 0.9%.

h Test performed using the Cubicin formulation.

i Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

k Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

l Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

m Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

n Tested as the premixed infusion solution.

o Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.